Experiment description of studies that identified FBXL4 in exosomes

1 Experiment ID 274 MISEV standards ✔ EM EV Biophysical techniques ✔ TSG101|Alix|RAB5A|CD9|CD82|CD63|CD81 EV Enriched markers ✔ AIF EV Negative markers ✔ NTA EV Particle analysis Identified molecule protein Identification method Mass spectrometry PubMed ID 25844599     Organism Homo sapiens Experiment description Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. Authors Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T. Journal name Oncotarget Publication year 2015 Sample Prostate cancer cells Sample name DU145 - Docetaxel resistant Isolation/purification methods Filtration Ultracentrifugation Sucrose density gradient Flotation density 1.13-1.18 g/mL Molecules identified in the study Protein Methods used in the study Mass spectrometry Flow cytometry Western blotting

Protein-protein interactions for FBXL4

Protein Interactor ExoCarta ID Identification method PubMed Species 1 SKP1 6500 Reconstituted Complex Homo sapiens View the network

Pathways in which FBXL4 is involved

No pathways found